Dr. Greg Kato, a CSL Behring medical expert, is among three editors of a new, deeply researched text on sickle cell disease. They dedicated it to their patients.
In the last decade, research into sickle cell disease has been booming, stirring hope for patients that new treatments – and even cures – are on the horizon. With so much happening, it makes sense to gather fast-expanding knowledge in a comprehensive text.
CSL Behring’s Dr. Greg Kato took on that challenge, along with fellow editors Dr. Mark T. Gladwin and Dr. Enrico M. Novelli of the University of Pittsburgh Medical Center and School of Medicine. In their new book, Sickle Cell Disease, the doctors pulled together insights from 80 experts in the field. In its 34 chapters, the text covers genetics, vaso-occlusion, stroke, pregnant women and newborns, rare presentations, and gene therapy while also examining sickle cell disease in Jamaica, Brazil, India and Africa.
Kato and Gladwin wrote the chapter on hemolysis (when red blood cells rupture, sending hemoglobin into blood plasma) and endothelial dysfunction (excessive constriction of blood vessels). The book, from publisher McGraw Hill, will be published April 16.